UFP Technologies (UFPT) Investor presentation summary

Investment highlights

• Specializes in contract development and manufacturing for medical devices, sterile packaging, and custom engineered products, with $603M revenue in 2025 and a $1.7B market cap.

• Operates in six countries with over 5,000 team members, serving blue-chip customers and focusing on segments with long product lifecycles and high switching costs.

• Targets a large, growing, and fragmented global medical device market (~$518B) and a $100B outsourcing opportunity, with core focus on plastic products and single-use technologies.

Business model and differentiation

• Provides end-to-end solutions from early development and prototyping to full-scale manufacturing, supporting global OEMs, niche device makers, and start-ups.

• Leverages engineering, material, and manufacturing expertise to innovate and scale, building durable customer relationships with high switching costs.

• Offers differentiated material technologies in high-growth medical segments such as robotic-assisted surgery, cardiovascular, infection control, orthopedics, and wound care.

Growth strategy

• Pursues disciplined, customer-centric M&A to add new segments, customers, and technologies, while expanding geographic reach and operating talent.

• Focuses on organic growth through early development partnerships and manufacturing scale, targeting 12-18% blended annual growth.